Atrium Therapeutics, Inc. (RNA)
NASDAQ·Healthcare·Biotechnology
$11.57
+2.07%
Mkt Cap $200.14M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+116.2%
Consensus $25.00 vs current $11.57
NASDAQ·Healthcare·Biotechnology
$11.57
+2.07%
Mkt Cap $200.14M
No recent rating data.
Price Target (2 analysts)
$25.00
Range $25.00 – $25.00
+116.2%
Consensus $25.00 vs current $11.57